Conference Roundup

Stay up to date with the latest research, clinical insights, emerging trends, and innovations presented at leading optometry and eye care meetings.

Conference Roundup

Combined surgical and contact lens strategy improves vision in advanced keratoconus

A staged combination of cataract surgery, intrastromal corneal ring segment implantation, and semi-scleral rigid gas-permeable contact lenses provided meaningful visual rehabilitation in a highly myopic patient with advanced keratoconus, bilateral cataracts, and severe baseline visual impairment, according to a case report presented at the 44th Congress of the European Society of Cataract and Refractive Surgeons.... ...

Practice Management

AOA 2026: What is the best IOL for my patient?

Nick Bruns, OD, FAAO, shares key insights on matching today’s intraocular lens options to each patient’s unique needs while recapping his American...

Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

Jeff Banas, OD, FAAO, discusses his American Optometric Association Meeting presentation, highlighting the latest glaucoma technologies helping clinicians detect disease earlier and...

Myopia

Low-dose atropine and DIMS lenses slow myopia development in high-risk preschool children

Low-dose atropine and Defocus Incorporated Multiple Segments (DIMS) lenses helped stabilize refractive development in preschool children at high familial risk for myopia,...

Latest Conference Roundup Videos

Practice Management

AOA 2026: What is the best IOL for my patient?

Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

Neurotrophic Keratitis

If you have a dry eye patient without typical pain presentation, consider neurotrophic keratitis and this treatment option

Conference Roundup

Lower-dose pilocarpine does not affect ciliary muscle thickness

Neurotrophic Keratitis

Following FDA approval of cenegermin, referrals for neurotrophic keratitis have increased

Myopia

Eight-year findings from the Low-Concentration Atropine for Myopia Progression Study

Myopia

Dispelling myopia management myths

Conference Roundup

4 big questions in glaucoma care

Conference Roundup

Combined surgical and contact lens strategy improves vision in advanced keratoconus

Practice Management

AOA 2026: What is the best IOL for my patient?

Nick Bruns, OD, FAAO, shares key insights on matching today’s intraocular lens options to each patient’s unique needs while recapping his American Optometric Association Meeting presentation. Nick Bruns, OD, FAAO:... ...

Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

Jeff Banas, OD, FAAO, discusses his American Optometric Association Meeting presentation, highlighting the latest glaucoma technologies helping clinicians detect disease earlier and reduce patients’ dependence on eye drops. Jeff Banas,...

Myopia

Low-dose atropine and DIMS lenses slow myopia development in high-risk preschool children

Low-dose atropine and Defocus Incorporated Multiple Segments (DIMS) lenses helped stabilize refractive development in preschool children at high familial risk for myopia, according to a study presented at the ARVO...

Myopia

Atropine slows axial elongation over two years in MAD trial

A 2-year interim analysis of the Myopia Atropine Dose (MAD) randomized clinical trial found modest axial elongation in children treated with atropine. The findings were presented in a poster at...

Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

A case report presented at the Association of Cataract and Refractive Surgery (ASCRS) Annual Meeting highlights the successful management of severe keratoconjunctivitis sicca (KCS) and neurotrophic keratopathy (NK) secondary to autoimmune... ...

Neurotrophic Keratitis

Systemic abnormalities commonly found in neurotrophic keratopathy patients, study finds

Patients with neurotrophic keratopathy (NK) frequently exhibit underlying autoimmune, dysimmune, and metabolic abnormalities, highlighting the potential role of systemic conditions in the disease and supporting the use of broader serological...

Neurotrophic Keratitis

If you have a dry eye patient without typical pain presentation, consider neurotrophic keratitis and this treatment option

At SECO 2026, Katie Rachon, OD, of Virginia Eye Consultants, talks about a patient case that presented as dry eye disease but was actually stage 1 neurotrophic keratitis. She shared...

Myopia

Low-dose atropine shows greatest benefit in younger children with progressive myopia in Phase 3 STAR trial

New subgroup analyses from the Phase 3 STAR trial presented at the 51st Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus show that SYD-101 0.01%, a low-dose...

Neurotrophic Keratitis

Topical insulin as interim therapy in neurotrophic keratitis

An 84-year-old female with a history of cataracts and glaucoma was referred for evaluation and culturing of a corneal ulcer in the left eye extending into the visual axis. She...

Neurotrophic Keratitis

Case highlights a rare overlap of peripheral ulcerative keratitis and neurotrophic keratitis

At SECO 2026, Amanda Eslinger, OD, et al presented a complex case illustrating the diagnostic and management challenges of peripheral ulcerative keratitis (PUK) with concurrent neurotrophic keratitis (NK). The case...

Conference Roundup

Lower-dose pilocarpine does not affect ciliary muscle thickness

Mark Dunbar, OD, of the Bascom Palmer Eye Institute, spoke with Optometry 360 about his presentation at SECO 2026. The study found that low-dose pilocarpine had minimal to no effect...

Myopia

Sydnexis reports positive Phase 3 results for low-dose atropine in pediatric myopia

Sydnexis, Inc announced topline results from its Phase 3 STAR trial of SYD-101, a proprietary low-dose atropine formulation, showing significant reductions in myopia progression in children at AMCP Nexus 2025....